Perpetua Medical AB (publ) (STO:PERP.B)
Sweden · Delayed Price · Currency is SEK 3.490
-0.150 (-4.12%)
Jul 24, 2026, 1:03 PM CET
Perpetua Medical AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 4.12 | 1.19 | -2.2 | -18.28 | -19.16 | -13.71 |
Depreciation & Amortization | - | - | - | 0.18 | - | - |
Other Adjustments | -6.65 | -7.11 | -4.5 | 0.68 | 0.69 | 0.42 |
Change in Receivables | 1.25 | 0.27 | 0.4 | 0.93 | -0.59 | -1.84 |
Changes in Inventories | 0.02 | -0.1 | 0.7 | 0.09 | -0.42 | -0.24 |
Changes in Accounts Payable | -0.14 | 0.09 | -0.16 | -0.3 | -0.29 | 0.9 |
Changes in Accrued Expenses | 0.63 | 1.25 | -1.71 | 0.05 | 0.71 | 0.17 |
Changes in Income Taxes Payable | -0.13 | -0.27 | -0.11 | 0 | - | - |
Changes in Other Operating Activities | -0.28 | -0.78 | 0.56 | 0.67 | -0.12 | -1.04 |
Operating Cash Flow | -5.43 | -5.46 | -7.03 | -16.41 | -19.19 | -15.34 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -1.07 | -1.07 | 0 | 0 | -0.46 | -0.5 |
Sale of Property, Plant & Equipment | - | - | - | 0.1 | - | - |
Purchases of Intangible Assets | 0.77 | -1.68 | -0.03 | -0.62 | -1.05 | -0.61 |
Proceeds from Sale of Intangible Assets | - | 2.94 | 7 | 0 | - | - |
Purchases of Investments | - | - | - | - | 0.5 | -0.18 |
Cash Acquisitions | -8.44 | -8.44 | -3.56 | - | - | - |
Proceeds from Business Divestments | - | 0 | 1.01 | 0 | - | - |
Other Investing Activities | -0 | -0 | 0.35 | -0.35 | - | - |
Investing Cash Flow | -9.33 | -8.25 | 4.78 | -0.87 | -1.01 | -1.3 |
Long-Term Debt Issued | 8.77 | 8.77 | 4 | 0 | - | - |
Long-Term Debt Repaid | -0.17 | -0.13 | -0.06 | -0.33 | -0.36 | -0.33 |
Net Long-Term Debt Issued (Repaid) | 8.6 | 8.64 | 3.94 | -0.33 | -0.36 | -0.33 |
Issuance of Common Stock | 19.23 | 0 | 2.17 | 12.45 | 12.19 | 19.59 |
Net Common Stock Issued (Repurchased) | 19.23 | 0 | 2.17 | 12.45 | 12.19 | 19.59 |
Financing Cash Flow | 27.83 | 8.64 | 6.12 | 12.12 | 11.83 | 19.26 |
Net Cash Flow | 13.07 | -5.07 | 3.87 | -5.16 | -8.37 | 2.63 |
Free Cash Flow | -6.5 | -6.53 | -7.03 | -16.41 | -19.65 | -15.84 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -22.50% | -24.65% | -49.65% | -164.38% | -188.65% | -176.08% |
Free Cash Flow Per Share | -1.15 | -1.40 | -1.65 | -5.92 | -26.97 | -27.94 |
Levered Free Cash Flow | 9.33 | 10.21 | 0.75 | -17.92 | -20.11 | -14.76 |
Unlevered Free Cash Flow | -0.85 | 1.2 | -3.38 | -17.8 | -19.7 | -14.39 |